Aprogen Healthcare & Games Inc. Stock price

Equities

A109960

KR7109960005

Pharmaceuticals

End-of-day quote Korea S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
634 KRW -2.91% Intraday chart for Aprogen Healthcare & Games Inc. -7.31% -18.61%
Sales 2022 9.6B 7.12M Sales 2023 16.01B 11.88M Capitalization 51.55B 38.25M
Net income 2022 -5.61B -4.16M Net income 2023 4.3B 3.19M EV / Sales 2022 -1.5 x
Net cash position 2022 81.33B 60.35M Net Debt 2023 3.51B 2.6M EV / Sales 2023 3.44 x
P/E ratio 2022
-11.9 x
P/E ratio 2023
24.3 x
Employees 16
Yield 2022 *
-
Yield 2023
-
Free-Float 55.49%
More Fundamentals * Assessed data
Dynamic Chart
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Aprogen Healthcare & Games Inc. announced that it has received KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc. CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Aprogen Healthcare & Games Inc. announced that it has received KRW 20.000001189 billion in funding CI
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 20.000001189 billion in funding CI
Aprogen Healthcare & Games Inc. acquired an 89.86% stake in Aprogen, Inc. for KRW 2.2 billion. CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Aprogen Healthcare & Games Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc. CI
Osung Advanced Materials Co., Ltd. cancelled the acquisition of an additional 3.5% stake in S-MAC CO., Ltd. from Aprogen Healthcare & Games Inc.. CI
More news
1 day-2.91%
1 week-7.31%
Current month+14.65%
1 month+15.27%
3 months-17.66%
6 months-48.79%
Current year-18.61%
More quotes
1 week
631.00
Extreme 631
769.00
1 month
528.00
Extreme 528
783.00
Current year
528.00
Extreme 528
840.00
1 year
528.00
Extreme 528
2 495.00
3 years
528.00
Extreme 528
6 225.00
5 years
528.00
Extreme 528
7 400.00
10 years
528.00
Extreme 528
30 791.67
More quotes
Managers TitleAgeSince
Comptroller/Controller/Auditor 68 -
Members of the board TitleAgeSince
Director/Board Member 57 -
Director/Board Member 68 -
More insiders
Date Price Change Volume
24-03-28 634 -2.91% 919,317
24-03-27 653 -3.97% 868,200
24-03-26 680 -5.82% 1,671,255
24-03-25 722 -0.41% 1,221,017
24-03-22 725 0.00% 3,361,243

End-of-day quote Korea S.E., March 27, 2024

More quotes
Aprogen Healthcare & Games Inc., formerly LOCOJOY International Corporation, formerly ENUStech., Inc., is a Korea-based company engaged in the manufacture of wireless communication equipment. The Company mainly operates in two business segments: wireless solution segment and lighting control segment. Its wireless solution segment provides bluetooth hands-free products, wired and wireless Internet phones, universal serial bus (USB) dongles and others. Its lighting control segment provides unidirectional and bidirectional control systems, which are used for street and security lights. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock
  2. Equities
  3. Stock Aprogen Healthcare & Games Inc. - Korea S.E.